XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.91%5.37B | 12.69%1.41B | 11.94%1.35B | 9.61%1.3B | 13.41%1.32B | 10.41%4.8B | 9.63%1.25B | 10.78%1.21B | 11.73%1.19B | 9.54%1.16B |
Operating revenue | 11.91%5.37B | 6.90%1.41B | 11.46%1.32B | 9.61%1.3B | 13.41%1.32B | 10.41%4.8B | 9.72%1.31B | 10.79%1.18B | 13.97%1.19B | 11.52%1.16B |
Cost of revenue | 11.41%3.14B | 11.46%819.1M | 11.26%792.7M | 10.16%758.1M | 12.79%770.1M | 8.59%2.82B | 9.97%734.9M | 8.50%712.5M | 8.69%688.2M | 7.16%682.8M |
Gross profit | 12.63%2.23B | 14.46%585.9M | 12.92%558.3M | 8.86%543.1M | 14.30%545.9M | 13.10%1.98B | 9.15%511.9M | 14.23%494.4M | 16.21%498.9M | 13.15%477.6M |
Operating expense | 9.41%1.37B | 9.81%353.6M | 10.86%349.2M | 3.97%327.5M | 13.18%338.4M | 11.40%1.25B | 11.30%322M | 10.76%315M | 12.58%315M | 10.95%299M |
Selling and administrative expenses | 3.29%266.5M | 3.13%69.2M | 6.88%68.4M | -7.17%64.7M | 12.24%64.2M | 23.44%258M | 20.04%67.1M | 27.24%64M | 39.40%69.7M | 8.33%57.2M |
-General and administrative expense | 3.29%266.5M | 3.13%69.2M | 6.88%68.4M | -7.17%64.7M | 12.24%64.2M | 23.44%258M | 20.04%67.1M | 27.24%64M | 39.40%69.7M | 8.33%57.2M |
Depreciation amortization depletion | 9.38%299.6M | 11.27%78M | 16.49%78.4M | 0.41%72.9M | 10.02%70.3M | 12.44%273.9M | 10.74%70.1M | 8.37%67.3M | 20.00%72.6M | 10.75%63.9M |
-Depreciation and amortization | 9.38%299.6M | 11.27%78M | 16.49%78.4M | 0.41%72.9M | 10.02%70.3M | 12.44%273.9M | 10.74%70.1M | 8.37%67.3M | 20.00%72.6M | 10.75%63.9M |
Other operating expenses | 11.61%802.6M | 11.69%206.4M | 10.18%202.4M | 9.96%189.9M | 14.61%203.9M | 7.26%719.1M | 8.64%184.8M | 6.80%183.7M | 2.01%172.7M | 11.89%177.9M |
Operating profit | 18.13%864.5M | 22.33%232.3M | 16.56%209.1M | 17.24%215.6M | 16.18%207.5M | 16.12%731.8M | 5.68%189.9M | 20.89%179.4M | 23.01%183.9M | 17.04%178.6M |
Net non-operating interest income expense | 4.25%-137.4M | 5.44%-33M | 2.79%-34.9M | 5.51%-34.3M | 3.30%-35.2M | 18.33%-143.5M | 6.93%-34.9M | 6.02%-35.9M | 39.90%-36.3M | 8.08%-36.4M |
Non-operating interest expense | -4.25%137.4M | -5.44%33M | -2.79%34.9M | -5.51%34.3M | -3.30%35.2M | -18.33%143.5M | -6.93%34.9M | -6.02%35.9M | -39.90%36.3M | -8.08%36.4M |
Other net income (expense) | 19.05%22.5M | -78.57%2.1M | 540.00%9.6M | 30.56%4.7M | 52.50%6.1M | 610.81%18.9M | 12.64%9.8M | 151.72%1.5M | 155.38%3.6M | 233.33%4M |
Earnings from equity interest | -6.25%3M | -77.78%200K | -30.00%700K | 55.56%1.4M | 75.00%700K | 10.34%3.2M | 200.00%900K | 42.86%1M | -10.00%900K | -55.56%400K |
Special income (charges) | ---600K | ---200K | ---400K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Less:Other special charges | --600K | --200K | --400K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 28.03%20.1M | -76.40%2.1M | 1,760.00%9.3M | 22.22%3.3M | 50.00%5.4M | 401.92%15.7M | 5.95%8.9M | 113.89%500K | 142.19%2.7M | 200.00%3.6M |
Income before tax | 23.45%749.6M | 22.21%201.4M | 26.76%183.8M | 23.02%186M | 22.02%178.4M | 34.69%607.2M | 9.21%164.8M | 35.14%145M | 83.05%151.2M | 32.91%146.2M |
Income tax | 13.62%150.2M | 1.08%37.6M | 18.81%36M | 16.77%38.3M | 20.06%38.3M | 32.07%132.2M | 16.61%37.2M | 38.99%30.3M | 43.86%32.8M | 35.17%31.9M |
Net income | 28.86%596.6M | 37.87%164.2M | 29.72%147.1M | 25.00%146.5M | 22.51%138.8M | 26.54%463M | 1.36%119.1M | 69.25%113.4M | 64.38%117.2M | 2.91%113.3M |
Net income continuous Operations | 26.19%599.4M | 28.37%163.8M | 28.86%147.8M | 24.75%147.7M | 22.57%140.1M | 35.44%475M | 7.23%127.6M | 34.15%114.7M | 97.99%118.4M | 32.29%114.3M |
Net income discontinuous operations | 76.67%-2.8M | 104.71%400K | 46.15%-700K | 0.00%-1.2M | -30.00%-1.3M | -178.95%-12M | -466.67%-8.5M | 92.97%-1.3M | -110.43%-1.2M | -104.22%-1M |
Minority interest income | 26.94%140.9M | 37.46%43.3M | 38.43%38.9M | 25.58%32.4M | 2.73%26.3M | 16.97%111M | 12.10%31.5M | 30.09%28.1M | 14.16%25.8M | 13.27%25.6M |
Net income attributable to the parent company | 29.46%455.7M | 38.01%120.9M | 26.85%108.2M | 24.84%114.1M | 28.28%112.5M | 29.89%352M | -2.01%87.6M | 87.89%85.3M | 87.68%91.4M | 0.23%87.7M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 33.33%800K | 100.00%2.4M | 600K | |||||||
Net income attributable to common stockholders | 30.35%455.7M | 41.90%120.9M | 26.85%108.2M | 24.78%113.3M | 28.28%112.5M | 29.58%349.6M | -3.40%85.2M | 87.89%85.3M | 86.45%90.8M | 0.23%87.7M |
Basic earnings per share | 29.06%4.53 | 37.93%1.2 | 27.06%1.08 | 24.18%1.13 | 27.27%1.12 | 29.04%3.51 | -2.25%0.87 | 88.89%0.85 | 85.71%0.91 | 0.00%0.88 |
Diluted earnings per share | 28.53%4.46 | 37.21%1.18 | 26.19%1.06 | 24.44%1.12 | 26.44%1.1 | 28.52%3.47 | -3.37%0.86 | 86.67%0.84 | 83.67%0.9 | 0.00%0.87 |
Dividend per share | 6.67%0.64 | 13.33%0.17 | 13.33%0.17 | 0.00%0.15 | 0.00%0.15 | -30.23%0.6 | 0.00%0.15 | 0.00%0.15 | -46.43%0.15 | -46.43%0.15 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |